Polyphenols sensitization potentiates susceptibility of mcf-7 and mda mb-231 cells to centchroman

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Singh, Neetu ^a   Zaidi, Deeba ^a   Shyam, Hari ^a   Sharma, Ramesh ^a   Balapure, Anil Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CATALASE; CENTCHROMAN; CURCUMIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SERINE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMAN; HUMAN CELL; INCUBATION TIME; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION STATE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SHAPE; CENTCHROMAN; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ESTROGEN RECEPTOR ALPHA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHOSPHOSERINE; POLYPHENOLS; REACTIVE OXYGEN SPECIES; STILBENES; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863088958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037736     Document Type: Article

References (45)

1. Renoir JM, Bouclier C, Seguin A, (2008) Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells. J Mol Endocrinol 40: 101-112.
2. Nigam M, Singh N, Ranjan V, Zaidi D, Sharma R, et al. (2010) Centchroman mediated apoptosis involves cross-talk between extrinsic/ intrinsic pathways and oxidative regulation. Life Sci 87: 750-758.
3. Nigam M, Ranjan V, Srivastava S, Sharma R, Balapure AK, (2008) Centchroman induces G0/ G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells. Life Sci 82: 577-590.
4. Misra NC, Nigam PK, Gupta R, Agarwal AK, Kamboj VP, (1989) 'Centchroman-a non-steroidal anti-cancer agent for advanced breast cancer: phase-II study. Int J Cancer 43 (5): 781-783.
5. Macgregor JI, Jordan VC, (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50: 151-196.
6. Martin KR, Appel CL, (2010) Polyphenols as dietary supplements: A double-edged sword. Nutrition and Dietary Supplements 2: 1-12.
7. Mense SM, Hei TK, Ganju RK, Bhat HK, (2008) Phytoestrogens and Breast Cancer Prevention: Possible Mechanisms of Action. Environ Health Perspect 116: 426-433.
8. Rice S, Whitehead SA, (2006) Phytoestrogens and breast cancer -promoters or protectors? Endocrine-Related Cancer 13: 995-1015; 2006.
9. Blesson CS, Awasthi S, Kharkwal G, Daverey A, Dwivedi A, (2006) Modulation of estrogen receptor transactivation and estrogen induced genes expression by Ormeloxifene-a triphenylethylene derivative. Steroids 71: 993-1000.
10. Mueller SO, Simon S, Chae K, Metzler M, Korach KS, (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80(1): 14-25.
11. López-Lázaro M, (2008) Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Mol Nutr Food Res 52: S103-S127.
12. Nakagawa-Goto K, Yamada K, Nakamura S, Chen TH, Chiang PC, et al. (2007) Antitumor agents 258 Syntheses and evaluation of dietary antioxidant-taxoid conjugates as novel cytotoxic agents. Bioorg Med Chem Lett 17: 5204-5209.
13. Lal J, (2010) Clinical pharmacokinetics and interaction of centchroman - A mini review. Contraception 81: 275-280.
14. Singh N, Nigam M, Ranjan V, Sharma R, Balapure AK, et al. (2009) Caspase mediated enhanced apoptotic action of Cyclophosphamide and Resveratrol treated MCF-7 cells. J Pharmacol Sci 109(4): 473-485.
15. Singh N, Nigam M, Ranjan V, Zaidi D, Garg VK, et al. (2011) Resveratrol as an adjunct therapy in cyclophosphamide-treated MCF-7 cells and breast tumor explants. Cancer Science 102: 1059-1067.
16. McCord JM, Fridovich I, (1969) Superoxide dismutase: an enzymatic function for erythrocupein. J Biol Chem 244: 6049-6055.
17. Beutler E, (1975) Catalase In: Beutler E, ed Red Cell Metabolism, A Manual of Biochemical Methods. New York: Academic Press; 89-90.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275.
19. Havens CG, Alan HoA, Yoshioka N, Dowdy SF, (2006) Regulation of Late G1/S Phase Transition and APCCdh1 by Reactive Oxygen Species. Mol Cell Biol 26(12): 4701-4711.
20. Felty Q, Singh KP, Roy D, (2005) Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 24: 4883-4893.
21. Filomeni G, Graziani I, Rotilio G, Ciriolo MR, (2007) trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2: 295-305.
22. Kelkel KM, Jacob C, Dicato M, Diederichkel M, (2010) Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies. Molecules 15: 7035-7074.
23. Waris G, Ahsan H, (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5: 14.
24. Fulda S, (2010) Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov Today 15(17-18): 757-765.
25. Syng-ai C, Kumari AL, Kharn A, (2004) Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Mol Cancer Ther 3: 1101-1108.
26. Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, (2003) The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 10 (3): 323-334.
27. Wada T, Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849.
28. Lannigan D, (2003) Estrogen receptor phosphorylation. Steroids 68: 1-9.
29. Fridman JS, Lowe SW, (2003) Control of apoptosis by p53. Oncogene 22: 9030-9040.
30. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, et al. (2010) Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 3: 11.
31. Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, et al. (2007) Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 28 (9): 1274-1304.
32. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB, (2008) Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Letters 267: 133-164.
33. Benhar M, Engelberg D, Levitzki A, (2002) ROS, Stress-activated kinases and stress signaling in cancer. EMBO Reports 3: 420-425.
34. Torres M, (2003) Mitogen-activated protein kinase pathways in redox signaling'. Front Biosci 8: 369-391.
35. Gosslau A, Chen KYu, (2004) Nutraceuticals, Apoptosis, and Disease Prevention. Nutrition 20: 95-102.
36. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM, (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF7 but not in MDA-MB-231 human breast cancer cells: cell specific alteration of the cell cycle. Biochem Pharmacol 64: 1375-1386.
37. Choudhuri T, Pal S, Das T, Sa G, (2005) Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280: 20059-20068.
38. Sa G, Das T, (2008) Anti cancer effects of curcumin: cycle of life and death. Cell Division 3: 14.
39. D'Archivio M, Santangelo C, Scazzocchio B, Rosaria V, Filesi C, et al. (2008) Modulatory Effects of Polyphenols on Apoptosis Induction: Relevance for Cancer Prevention. Int J Mol Sci 9: 213-228.
40. Conklin KA, (2004) Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness Integrative Cancer Therapies 3(4): 294-300.
41. She QB, Huang C, Zhang Y, Dong Z, (2002) Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinog 33: 244-250.
42. Ravindran J, Prasad S, Aggarwal BB, (2009) Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS J 11(3): 495-510.
43. Aggarwal BB, Shishodia (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421.
44. Murias M, Luczak MW, Niepsuj A, Krajka-Kuzniak V, Zielinska-Przyjemska M, et al. (2008) Cytotoxic activity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase. Toxicol In Vitro. 22(5): 1361-1370.
45. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G, (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512(1-3): 334-340.